Amneal Pharmaceuticals Inc (AMRX)
6.76
+0.55
(+8.86%)
USD |
NASDAQ |
May 03, 16:00
6.765
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Price: 6.76 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 6.25 | 6.90 | 5.81 | 6.76 | 3.849M |
| May 02, 2024 | 6.20 | 6.35 | 6.08 | 6.21 | 2.166M |
| May 01, 2024 | 6.02 | 6.19 | 5.995 | 6.12 | 1.246M |
| Apr 30, 2024 | 5.89 | 6.099 | 5.815 | 6.05 | 1.966M |
| Apr 29, 2024 | 5.86 | 5.97 | 5.825 | 5.94 | 1.265M |
| Apr 26, 2024 | 5.90 | 5.975 | 5.84 | 5.87 | 959058.0 |
| Apr 25, 2024 | 5.97 | 5.97 | 5.59 | 5.90 | 3.428M |
| Apr 24, 2024 | 5.76 | 6.11 | 5.56 | 6.05 | 3.066M |
| Apr 23, 2024 | 5.41 | 5.48 | 5.355 | 5.40 | 1.382M |
| Apr 22, 2024 | 5.41 | 5.43 | 5.18 | 5.37 | 1.848M |
| Apr 19, 2024 | 5.33 | 5.43 | 5.33 | 5.42 | 1.058M |
| Apr 18, 2024 | 5.46 | 5.47 | 5.34 | 5.36 | 843286.0 |
| Apr 17, 2024 | 5.52 | 5.52 | 5.37 | 5.46 | 1.220M |
| Apr 16, 2024 | 5.48 | 5.54 | 5.38 | 5.45 | 1.204M |
| Apr 15, 2024 | 5.50 | 5.67 | 5.47 | 5.54 | 1.118M |
| Apr 12, 2024 | 5.68 | 5.81 | 5.42 | 5.52 | 2.185M |
| Apr 11, 2024 | 5.72 | 5.81 | 5.65 | 5.69 | 1.275M |
| Apr 10, 2024 | 5.70 | 5.92 | 5.61 | 5.70 | 1.777M |
| Apr 09, 2024 | 6.00 | 6.03 | 5.72 | 5.73 | 2.314M |
| Apr 08, 2024 | 6.16 | 6.330 | 5.96 | 6.00 | 1.377M |
| Apr 05, 2024 | 5.95 | 6.195 | 5.925 | 6.12 | 1.991M |
| Apr 04, 2024 | 6.10 | 6.21 | 5.94 | 5.96 | 1.231M |
| Apr 03, 2024 | 5.75 | 6.120 | 5.67 | 6.02 | 1.823M |
| Apr 02, 2024 | 5.99 | 6.00 | 5.78 | 5.81 | 1.221M |
| Apr 01, 2024 | 6.07 | 6.13 | 5.90 | 6.05 | 1.186M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.27
Minimum
Mar 28 2023
14.05
Maximum
May 06 2019
4.184
Average
4.22
Median
Aug 11 2020
Price Benchmarks
| Fate Therapeutics Inc | 4.06 |
| Ocular Therapeutix Inc | 6.17 |
| Editas Medicine Inc | 5.67 |
| AnaptysBio Inc | 26.58 |
| AEON Biopharma Inc | 1.70 |
Price Related Metrics
| PS Ratio | 0.5021 |
| Price to Book Value | 104.92 |
| Price to Free Cash Flow | 4.348 |
| Earnings Yield | -7.25% |
| Market Cap | 2.075B |
| Operating PE Ratio | 5.359 |